Avanos Medical Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
$1.00next fiscal year
Monitoring Framework
Key Performance Indicators
Specialty Nutrition Systems (SNS) Segment Net Sales Quarterly124MTarget: Continued double-digit organic growth to offset Pain Management segment headwinds
Adjusted Diluted Earnings Per Share (EPS) Quarterly0.2Target: Stabilization and expansion above historical baseline of $1.00+ annualized
Free Cash Flow Quarterly-16.6MTarget: Positive annual cash generation to support operational flexibility prior to merger close
Watch Items
- Shareholder Vote on American Industrial Partners (AIP) MergerTrigger: Affirmative vote of a majority of outstanding shares of Common StockAction: Monitor proxy voting outcomes and shareholder participation leading up to the special meeting
- Regulatory and Antitrust Clearances (HSR Act and Foreign Investment)Trigger: Expiration or termination of applicable waiting periods under the HSR Act and receipt of foreign regulatory approvalsAction: Track regulatory filings and any requests for additional information from antitrust authorities
- Spread Between Market Price and Merger ConsiderationTrigger: Market price trading significantly below or above the $25.00 cash offer priceAction: Assess market implied probability of deal completion or potential speculation of a transaction terms adjustment
Research as of 19 Jun 2026